Literature DB >> 11950804

Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques.

F Schäfer1, S Kewenig, N Stolte, C Stahl-Hennig, A Stallmach, F-J Kaup, M Zeitz, T Schneider.   

Abstract

BACKGROUND: Little is known about secretory immunity-the major defence mechanism at mucosal surfaces-in human immunodeficiency virus (HIV) infected patients, especially in the early stages of the disease. AIMS: The aim of the study was to analyse mucosal immunoglobulin production and simian immunodeficiency virus (SIV) specific antibody response in the intestinal mucosa during the course of SIV infection in comparison with serum and saliva. ANIMALS AND METHODS: IgG, IgA, and IgM concentrations were determined in supernatants of short term cultured duodenal biopsies, serum, and saliva from SIV infected rhesus macaques (n=8) and controls (n=2) by ELISA at defined times before and after infection. Specific antibodies to SIV were detected by western blot and/or dot blot analysis. In addition, rectal swabs from two uninfected and 12 SIV infected rhesus macaques (seven without and five with enteritis) were analysed for albumin and IgG concentrations.
RESULTS: An increase in total intestinal IgG and a decrease in IgA were observed. SIV specific IgG or IgA responses were detectable as early as one week after SIV infection in the serum of seven of eight animals. In contrast, intestinal SIV specific IgG production was detected only four weeks after infection in six of eight animals, and intestinal SIV specific IgA was not produced in the intestine at any time point. In saliva, the secretory component on SIV specific IgA was only detected in one animal at week 24 after infection. Enteritis is frequent in SIV infected animals and results in a significant increase in albumin and IgG secretion into the intestinal lumen.
CONCLUSION: Despite modest quantitative changes in mucosal immunglobulin production there was a total lack of SIV specific IgA synthesis in the intestine during SIV infection. This lack or disturbed secretory SIV specific IgA response at mucosal surfaces may explain the rapid and high HIV/SIV replication in this compartment. In addition, our investigations indicate secretion of serum proteins into intestinal fluids during SIV infection. Previous investigations using intestinal secretions or swabs for analysing quantitative and specific immunglobulins therefore should be interpreted with caution.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950804      PMCID: PMC1773198          DOI: 10.1136/gut.50.5.608

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  37 in total

1.  Paradoxical IgA immunity in CD4-deficient mice. Lack of cholera toxin-specific protective immunity despite normal gut mucosal IgA differentiation.

Authors:  C E Hörnquist; L Ekman; K D Grdic; K Schön; N Y Lycke
Journal:  J Immunol       Date:  1995-09-15       Impact factor: 5.422

2.  Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM.

Authors:  M Bomsel; M Heyman; H Hocini; S Lagaye; L Belec; C Dupont; C Desgranges
Journal:  Immunity       Date:  1998-08       Impact factor: 31.745

3.  IgA immunity in HIV type 1-infected chimpanzees. II. Mucosal immunity.

Authors:  K P Black; P N Fultz; M Girard; S Jackson
Journal:  AIDS Res Hum Retroviruses       Date:  1997-10-10       Impact factor: 2.205

4.  HIV-1 p24 but not proviral load is increased in the intestinal mucosa compared with the peripheral blood in HIV-infected patients.

Authors:  O T Fackler; M Schäfer; W Schmidt; T Zippel; W Heise; T Schneider; M Zeitz; E O Riecken; N Mueller-Lantzsch; R Ullrich
Journal:  AIDS       Date:  1998-01-22       Impact factor: 4.177

5.  Increased immunoglobulin G production by short term cultured duodenal biopsy samples from HIV infected patients.

Authors:  T Schneider; T Zippel; W Schmidt; G Pauli; U Wahnschaffe; S Chakravarti; W Heise; E O Riecken; M Zeitz; R Ullrich
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

6.  HIV-1/simian immunodeficiency virus infection of human and nonhuman primate lymphocytes results in the migration of CD2+ T cells into the intestine of engrafted SCID mice.

Authors:  H H Donze; J E Cummins; R S Schwiebert; A Kantele; Y Han; P N Fultz; S Jackson; J Mestecky
Journal:  J Immunol       Date:  1998-03-01       Impact factor: 5.422

7.  Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection.

Authors:  R S Veazey; M DeMaria; L V Chalifoux; D E Shvetz; D R Pauley; H L Knight; M Rosenzweig; R P Johnson; R C Desrosiers; A A Lackner
Journal:  Science       Date:  1998-04-17       Impact factor: 47.728

8.  Duodenal biopsies of HIV-infected patients with diarrhoea exhibit epithelial barrier defects but no active secretion.

Authors:  M Stockmann; M Fromm; H Schmitz; W Schmidt; E O Riecken; J D Schulzke
Journal:  AIDS       Date:  1998-01-01       Impact factor: 4.177

9.  Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier.

Authors:  M Bomsel
Journal:  Nat Med       Date:  1997-01       Impact factor: 53.440

10.  Abnormal predominance of IgG in HIV-specific antibodies produced by short-term cultured duodenal biopsy specimens from HIV-infected patients.

Authors:  T Schneider; T Zippel; W Schmidt; G Pauli; W Heise; U Wahnschaffe; E O Riecken; M Zeitz; R Ullrich
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-12-15
View more
  26 in total

1.  Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women.

Authors:  Jiri Mestecky; Peter F Wright; Lucia Lopalco; Herman F Staats; Pamela A Kozlowski; Zina Moldoveanu; Rashada C Alexander; Rose Kulhavy; Claudia Pastori; Leonard Maboko; Gabriele Riedner; Yuwei Zhu; Terri Wrinn; Michael Hoelscher
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-22       Impact factor: 2.205

2.  Robust vaccine-elicited cellular immune responses in breast milk following systemic simian immunodeficiency virus DNA prime and live virus vector boost vaccination of lactating rhesus monkeys.

Authors:  Andrew B Wilks; Elizabeth C Christian; Michael S Seaman; Piya Sircar; Angela Carville; Carmen E Gomez; Mariano Esteban; Giuseppe Pantaleo; Dan H Barouch; Norman L Letvin; Sallie R Permar
Journal:  J Immunol       Date:  2010-11-01       Impact factor: 5.422

Review 3.  How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?

Authors:  Per Johan Klasse; Rogier W Sanders; Andrea Cerutti; John P Moore
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-20       Impact factor: 2.205

4.  Mucosal and systemic antibody responses in humans infected with simian foamy virus.

Authors:  James E Cummins; Roumiana S Boneva; William M Switzer; Logan L Christensen; Paul Sandstrom; Walid Heneine; Louisa E Chapman; Charlene S Dezzutti
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model.

Authors:  Thorsten Demberg; Venkatramanan Mohanram; David Venzon; Marjorie Robert-Guroff
Journal:  Clin Immunol       Date:  2014-05-09       Impact factor: 3.969

Review 6.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

Review 7.  Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection.

Authors:  Jiri Mestecky; Zina Moldoveanu; Phillip D Smith; Zdenek Hel; Rashada C Alexander
Journal:  J Reprod Immunol       Date:  2009-10-23       Impact factor: 4.054

8.  Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy.

Authors:  D E Nilssen; O Øktedalen; P Brandtzaeg
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

9.  Frequent intratype neutralization by plasma immunoglobulin a identified in HIV type 2 infection.

Authors:  Gülşen Özkaya Şahin; Fredrik Månsson; Angelica A Palm; Elzbieta Vincic; Zacarias da Silva; Patrik Medstrand; Hans Norrgren; Eva Maria Fenyö; Marianne Jansson
Journal:  AIDS Res Hum Retroviruses       Date:  2012-11-21       Impact factor: 2.205

10.  HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits.

Authors:  Weifeng Xu; Paul A Santini; John S Sullivan; Bing He; Meimei Shan; Susan C Ball; Wayne B Dyer; Thomas J Ketas; Amy Chadburn; Leona Cohen-Gould; Daniel M Knowles; April Chiu; Rogier W Sanders; Kang Chen; Andrea Cerutti
Journal:  Nat Immunol       Date:  2009-08-02       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.